Apr
14
NIH begins trial of anti-CD14 antibody to treat respiratory disease caused by COVID-19
The following article is re-printed from a news release issued by the National Institutes of Health. A clinical trial testing the safety and efficacy of an investigational monoclonal antibody for treating people who are hospitalized with respiratory disease and low blood oxygen due to infection with SARS-CoV-2, the virus that causes COVID-19, has begun. The … Read more